Primary care team- and clinic level factors affecting HPV vaccine uptake

Vaccine

Volumn 35, Issue 35, 2017, Pages 4540-4547

  Chuang, Emmeline ^a,b   Cabrera, Claudia ^c   Mak, Selene ^a   Glenn, Beth ^a,b   Hochman, Michael ^d   Bastani, Roshan ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Adolescent; Human papillomavirus; Mixed methods research; Vaccine

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; CASE STUDY; CHILD; CONTROLLED STUDY; FACTOR ANALYSIS; FEMALE; HEALTH CARE FACILITY; HEALTH CARE MANAGEMENT; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH PERSONNEL ATTITUDE; HISPANIC; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PAPILLOMAVIRUS INFECTION; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PEDIATRICS; PREVENTIVE MEDICINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; RECOMMENDED DRUG DOSE; RESPONSIBILITY; SCHOOL CHILD; SEMI STRUCTURED INTERVIEW; VACCINATION; ATTITUDE TO HEALTH; ETHNOLOGY; OUTPATIENT DEPARTMENT; PREVENTIVE HEALTH SERVICE; PRIMARY HEALTH CARE; PSYCHOLOGY; VACCINATION COVERAGE;

ADOLESCENT; AMBULATORY CARE FACILITIES; CHILD; COMMUNICATION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HISPANIC AMERICANS; HUMANS; IMMUNIZATION PROGRAMS; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; PRIMARY HEALTH CARE; VACCINATION; VACCINATION COVERAGE;

EID: 85025467862     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2017.07.028     Document Type: Article

References (49)

1. Munoz, N., Castellsague, X., Berrington de Gonzalez, A., Gissmann, L., HPV in the etiology of human cancer. Vaccine 24:S3 (2006), 1–10.
2. Jemal, A., Simard, E., Dorell, C., et al. Annual report to the nation on the status of cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 105:3 (2013), 175–201.
3. Centers for Disease Control and Prevention, Human papillomavirus-associated cancers - United States, 2004–2008. Morb Mortal Wkly Rep 61:15 (2012), 258–261.
4. Dunne, E., Markowitz, L., Saraiya, M., et al. CDC grand rounds: reducing the burden of HPV-associated cancer and disease. MMWR. 63:4 (2014), 69–72.
5. Paavonen, J., Naud, P., Salmeron, J., et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomized study in young women. Lancet 356:9686 (2009), 301–314.
6. Group FIS, Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 356 (2007), 1915–1927.
7. Giuliano, A., Palefsky, J., Goldstone, S., et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med 364:5 (2011), 401–411.
8. Koutsky, L., Harper, D., Current findings from prophylactic HPV vaccine trials. Vaccine S3 (2006), 114–121.
9. Clifford, G., Smith, J., Plummer, M., Munoz, N., Franceschi, S., Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88:1 (2003), 63–73.
10. Goldstone, S., Jessen, H., Palefsky, J., et al. Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. Vaccine 31:37 (2013), 3849–3855.
11. Joura, E., Giuliano, A., Iversen, O., et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 372 (2015), 711–723.
12. Markowitz, L., Dunne, E., Saraiya, M., Lawson, H., Chesson, H., Unger, E., Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations Rep 56:RR02 (2007), 1–24.
13. Centers for DIsease Control and Prevention, FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 59:20 (2010), 626–629.
14. Centers for Disease Control and Prevention, National and state vaccination coverage among adolescents aged 13–17 years - United States, 2012. Morb Mortal Wkly Rep 62:34 (2013), 685–693.
15. Reagan-Steiner, S., Yankey, D., Jeyarajah, J., et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years - United States, 2015. Morb Mortal Wkly Rep 65:33 (2016), 850–858.
16. Staras, S., Vadaparampil, S., Patel, R., Shenkman, E., Parent perceptions important for HPV vaccine initiation among low-income adolescent girls. Vaccine 32 (2014), 6163–6169.
17. Fisher, H., Trotter, C., Audrey, S., MacDonald, K., Hickman, M., Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis. Int J Epidemiol 42:3 (2013), 896–908.
18. Niccolai, L., Mehta, N., Hadler, J., Racial/ethnic and poverty disparities in human papillomavirus vaccination completion. Am J Prev Med 41:4 (2011), 428–433.
19. Widdice, L., Bernstein, D., Leonard, A., Marsolo, K., Kahn, J., Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics 127 (2011), 77–84.
20. Bednarczyk, R., Curran, E., Orenstein, W., Omer, S., Health disparities in human papillomavirus vaccine coverage: trends analysis from the National Immunization Survey-Teen, 2008–2011. Clin Infect Dis, 2013.
21. Chao, C., Slezak, J., Coleman, K., Jacobsen, S., Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health 99:6 (2009), 1137–1142.
22. Hechter, R., Chao, C., Sy, L., et al. Quadrivalent human papillomavirus vaccine uptake in adolescent boys and maternal utilization of preventive care and history of sexually transmitted infections. Am J Public Health 103:9 (2013), e63–e68.
23. Kessels, S., Marshall, H., Watson, M., Braunack-Mayer, A., Reuzel, R., Tooher, R., Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 30 (2012), 3546–3556.
24. Kester, L., Zimet, G., Fortenberry, J.D., Kahn, J., Shew, M., A national study of HPV vaccination of adolescent girls: Rates, predictors, and reasons for non-vaccination. Matern Child Health J 17 (2013), 879–885.
25. Reiter, P., Gupta, K., Brewer, N., et al. Provider-verified HPV vaccine coverage among a national sample of Hispanic adolescent females. Cancer Epidemiol Biomark Prev 23:5 (2014), 742–754.
26. Rosenthal, S., Weiss, T.W., Zimet, G., Ma, L., Good, M., Vichnin, M., Predictors of HPV vaccine uptake among women aged 19–26: importance of a physician's recommendation. Vaccine 29 (2011), 890–895.
27. Malo, T., Hassani, D., Staras, S., Shenkman, E., Giuliano, A., Vadaparampil, S., Do Florida Medicaid providers' barriers to HPV vaccination vary based on VFC program participation?. Matern Child Health J 17 (2013), 609–615.
28. Vadaparampil, S., Kahn, J., Salmon, D., et al. Missed clinical opportunities: Provider recommendations for HPV vaccination for 11–12 year old girls are limited. Vaccine 5 (2011), 8634–8641.
29. Kahn, J., Zimet, G., Bernstein, D., et al. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health 37 (2005), 502–510.
30. Holder, N., Katzenellenbogen, R., Middleman, A., Human papillomavirus vaccines: factors that affect vaccine knowledge and delivery. J Adolesc Health 53 (2013), 423–425.
31. Polonijo, A., Carpiano, R., Social inequalities in adolescent human papillomavirus (HPV) vaccination: a test of fundamental cause theory. Soc Sci Med 82 (2013), 115–125.
32. Gilkey, M., Calo, W., Moss, J., Shah, P., Marciniak, M., Brewer, N., Provider communication and HPV vaccination: the impact of recommendation quality. Vaccine. 34 (2016), 1187–1192.
33. Stange, K., Nutting, P., Miller, W., et al. Defining and measuring the patient-centered medical home. J Gen Intern Med 25:6 (2010), 601–612.
34. Goldberg, D., Beeson, T., Kuzel, A., Love, L., Carver, M., Team-based care: a critical element of primary care practice transformation. Population Health Manage 16:3 (2013), 150–156.
35. Ferrante, J., Balasubramanian, B., Hudson, S., Crabtree, B., Principles of the patient-centered medical home and preventive services delivery. Ann Family Med 8:2 (2010), 108–116.
36. StataCorp. Stata Statistical Software: Release 13. College Station (TX): StataCorp LP; 2013.
37. King, N., Doing template analysis. Cassell, G.S.C., (eds.) Qualiatitatve organizational methods: core methods and current challenges, 2012, Sage, Thousand Oaks (CA), 426–450.
38. Vadaparampil, S., Staras, S., Malo, T., et al. Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year old girls. Cancer 119 (2013), 621–628.
39. Ylitalo, K., Lee, H., Mehta, N., Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health 103:1 (2013), 164–169.
40. Chuang, E., Brunner, J., Mak, S., et al. Challenges with implementing a patient-centered medical home model for women veterans. Women's Health Issues, 2017.
41. Tierney, C., Yusuf, H., McMahon, S., Rusinak, D., O'Brien, M., Massoudi, M., Adoption of reminder and recall messages for immunization by pediatricians and public health clinics. Pediatrics, 2003(112), 2003, 5.
42. Humiston, S., Rosenthal, S., Challenges to vaccinating adolescents: vaccine implementation issues. Pediatr Infect Dis J 24:S6 (2005), 134–140.
43. Farrar, B., Morgan, J., Chuang, E., Konrad, T.R., Growing your own: community health workers and jobs to careers. J Ambulatory Care Manage 34:3 (2011), 234–246.
44. Rosenthal, E., Brownstein, J., Rush, C., et al. Community health workers: part of the solution. Health Aff 29:7 (2010), 1338–1342.
45. Riddick, S., Improving access for limited English-speaking consumers: a review of strategies in health care settings. J Health Care Poor Underserved 9 (1998), S40–S61.
46. Friedman, A., Shepeard, H., Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV. Health Educ Behav 34:3 (2007), 471–485.
47. Gilkey, M., Moss, J., Coyne-Beasley, T., Hall, M., Shah, P., Brewer, N., Physician communication about adolescent vaccination: how is human papillomavirus different?. Prev Med 77 (2015), 181–185.
48. Keim-Malpass, J., McKim, M., Camacho, F., HPV vaccination series completion and co-vaccination: pairing vaccines may matter for adolescents. Vaccine 33:43 (2015), 5729–5732.
49. Tissot, A., Zimet, G., Rosenthal, S., Bernstein, D., Wetzel, C., Kahn, J., Effective strategies for HPV vaccine delivery: the views of pediatricians. J Adolesc Health 41:2 (2007), 119–125.